Hypertension OK Now in Hand, Novartis Expanding Entresto Pitch to GPs with Superior Efficacy over ARBs

Adriaan Kooy, Corporate Officer, Cardiovascular, Renal & Metabolism Business Franchise, Novartis Pharma Since the debut of Novartis’ heart failure treatment Entresto (sacubitril valsartan sodium hydrate) in Japan last year, the company has been promoting the medicine primarily for hospital specialists...read more